Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 1416-1420, 2021.
Article in Chinese | WPRIM | ID: wpr-881275

ABSTRACT

OBJECTIVE:To provid e reference for the medicinal resources and clinical application of Tibetan medicine “Dida”. METHODS:Delphi method was adopted. By reviewing literatures ,confirming consultation scope ,inviting experts engaged in clinical,scientific research ,teaching and production of Tibetan medicine. Two methods ,online inquiry and on-site questionnaire , were used for expert consultation to evaluate the differences and problems existing in the utilization of “Dida”medicinal resources until a consensus was reached ,consensus on the medicinal resources and clinical application of Tibetan medicine “Dida”was determined finally. RESULTS & CONCLUSIONS :A total of 33 experts participated in the two rounds of consultation. According to the results of literature research ,the first round set up 16 inquiry indicators ;and then according to expert opinions to modify the index system ,the second round set up 18 inquiry indicators. After two rounds of inquiry ,a consensus was finally reached on 16 items on the original name ,quality standards and clinical application of Tibetan medicine “Dida”,and 2 items related to the characteristics and compatibilities of “Dida”had not reach common views. The consensuses of 16 items mainly cover the original name of “Dida”and the evolution of geographic information ,the rational selection of “Dida”medicinal materials ,the effectiveness and safety of clinical use of “Dida”.

2.
Chinese Journal of Pharmacology and Toxicology ; (6): 931-938, 2015.
Article in Chinese | WPRIM | ID: wpr-484097

ABSTRACT

OBJECTIVE To study the effect of the ethanol extract of Fructus Psoraleae(EEFP)on endogenous metabolites in rat urine based on metabolomics. METHODS Male SD rats were orally administered with EEFP at the doses of 0.54,1.08 and 1.62 g · kg-1,respectively,once a day for two consecutive weeks. Urine samples were collected for 12 h after the last administration. Data were acquired with the MassLynx software based on ultra-performance liquid chromatography quadrupole-time-of-flight mass spectrometry(UPLC-Q-TOF-MS). The principal component analysis(PCA)and partial least squares-discriminant analysis(PLS-DA)were used to analyze the difference of endogenous metabolites in different groups,then putative biomarkers were found through the orthogonal partial least-squares-discriminant analysis(OPLS-DA),variable importance in the projection(VIP)and t test and their relative intensity were determined. RESULTS The results of PCA showed that samples of each group were clustered,all the groups were separated,and that the distance between the EEFP groups and the blank control group was increased in a dose-dependent manner. The relative contents of p-cresol glucuronide and galactose-beta-1,4-xylose were 40.0 ± 11.2,2.7 ± 2.6,16.8 ± 6.3 and 45.9 ± 16.4,32.6±22.1,8.0±8.3 in the EEFP 0.54,1.08 and 1.62 g·kg-1 groups,respectively,significantly lower than those of the control group,which were 107.0 ± 26.9 and 82.3 ± 13.6(P<0.01),respectively. The relative contents of 5-L-glutamyl-taurine,and gluconolactone were 22.4 ± 10.0,47.6 ± 19.1 and 138.2 ± 18.8,337.3±64.0 in EEFP 1.08 and 1.62 g·kg-1groups,respectively,significantly higher than those of the blank control group,which were 2.6±1.6 and 20.5±6.8,respectively(P<0.01). The relative content of D-pantothenoyl-L-cysteine was 74.2 ± 31.5 in the EEFP 1.62 g · kg-1 group,significantly higher than that in the blank control group(0.6±0.5)(P<0.01). As the dose of EEFP increased,D-pantothenoyl-L-cysteine,5-L-glutamyl-taurine,and gluconolactone had an upward trend(P<0.01),while galactose-beta-1,4-xylose and p-cresol glucuronide had a downward trend(P<0.01). CONCLUSION The two-week administration of EEFP has effect on the endogenous metabolites in urine. The substances identified are mainly related to energy metabolism,taurine,tyrosine and glucose metabolism.

3.
Chinese Medical Ethics ; (6)1996.
Article in Chinese | WPRIM | ID: wpr-524146

ABSTRACT

There are many chances to meet with ethical problems in the use of pharmacology, so it's necessary to combine the education of medical ethics with pharmacology teaching. Several methods can be used. The first is to build up models for students. The teacher's diathesis should be cultivated and strengthened to further the education of medical ethics in pharmacology teaching. At the same time, medical staff with noble morality can be taken for example to guide the students to develop their personality and self-cultivation, which will contribute to the foundation of human culture as well as the appropriate application of professional knowledge. The second is to collect, coordinate and renewal the information of medical ethics from internet, mass medium and historical materials, etc, so as to maintain a fresh feeling of teaching. Meanwhile, the introduction of medical ethics will encourage the students to rethink the value of study and improve the recognition of the meaning in the fields of medicine. The third is to select suitable content and chance to combine both without increasing the periods of pharmacological studies. The last method is to discuss and perfect the efficiency of estimation system. It will be discussed later.

SELECTION OF CITATIONS
SEARCH DETAIL